CEO of Biomarin Pharmaceutical, Inc. (BMRN, Financial) Jean Jacques Bienaime sells 6,000 shares of BMRN on 12/10/2012 at an average price of $47.53 a share.
Biomarin Pharmaceutical, Inc. has a market cap of $5.99 billion; its shares were traded at around $49.58 with and P/S ratio of 12.
For the complete insider trading history of BMRN, click here.
Biomarin Pharmaceutical, Inc. has a market cap of $5.99 billion; its shares were traded at around $49.58 with and P/S ratio of 12.
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 6,000 shares of BMRN stock on 12/10/2012 at the average price of 47.53. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 4.31% since.
- CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/04/2012 at the average price of 47.94. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 3.42% since.
- CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 11/16/2012 at the average price of 48.05. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 3.18% since.
- CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 11/14/2012 at the average price of 48.5. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2.23% since.
- CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 11/09/2012 at the average price of 47.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 4.12% since.
Directors and Officers Recent Trades:
- Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 0.83% since.
- SVP, Chief Commercial Of Jeffrey Robert Ajer sold 5,916 shares of BMRN stock on 11/28/2012 at the average price of 48.31. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has increased by 2.63% since.
- VP, Human Resources Mark Wood sold 2,665 shares of BMRN stock on 11/23/2012 at the average price of 48.92. Mark Wood owns at least 32,364 shares after this. The price of the stock has increased by 1.35% since.
- SVP, General Counsel George Eric Davis sold 7,363 shares of BMRN stock on 11/19/2012 at the average price of 48.5. George Eric Davis owns at least 51,322 shares after this. The price of the stock has increased by 2.23% since.
- EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 11/15/2012 at the average price of 51. Robert Baffi owns at least 100,413 shares after this. The price of the stock has decreased by 2.78% since.
For the complete insider trading history of BMRN, click here.
